Clinical Trial: Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Ovarian High Grade Serous Adenocarcinoma
Study Type: INTERVENTIONAL
Official Title: Phase II Clinical Trial Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Brief Summary:
This phase II trial test tests how well repurposing atovaquone works in treating patients with platinum-resistant ovarian cancer.Atovaquone is used for the treatment or prevention of certain infections.Atovaquone is in a class of medications called antiprotozoal agents.It works by stopping the growth of certain types of protozoa that can cause pneumonia.Giving atovaquone may be effective in treating platinum-resistant ovarian cancer and result in improved outcomes compared to standard chemotherapy regimens.
Read more